Anti-LMP2 TCR-T Cell Therapy for Treatment of EBV Associated Cancer

摘要

The present disclosure provides compositions comprising a population of anti-LMP2 TCR-T cells and methods of making and using the same for the treatment of EBV-associated cancers.